👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 97/100
Accepting new patients
Dr
Dr Daniel Krell
Oncology
English
8,624+
Patients seen
14
Years in practice
8
Publications
1
Languages spoken
About
Dr Daniel Krell is a Consultant Oncologist, specialising in colon, upper GI, lower GI and hepatobiliary cancers and neuroendocrine tumours.
He has expertise in the use of chemotherapy, targeted therapy and immunotherapy. Dr Krell is also the clinical lead for the management of patients with cancer of unknown primary. He is a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free London NHS Foundation Trust. He also holds the position of Clinical Lead for Neuroendocrine Tumour Oncology at The Royal Free Hospital.
Dr Krell completed his medical degree at the University of Leeds in 2003. He later completed his specialist training in oncology at University College London and the Royal Free Hospital. He also holds a DPhil in Clinical Medicine gained from the University of Oxford's Wellcome Trust Centre for Human Genetics, funded by Cancer Research UK and HCA.
Dr Krell remains actively involved in clinical research and trials designed to find new cancer therapies for hepatobiliary, gastrointestinal and neuroendocrine tumours. He has published papers in peer-reviewed journals and has presented his work at both national and international conferences and meetings.
He has expertise in the use of chemotherapy, targeted therapy and immunotherapy. Dr Krell is also the clinical lead for the management of patients with cancer of unknown primary. He is a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free London NHS Foundation Trust. He also holds the position of Clinical Lead for Neuroendocrine Tumour Oncology at The Royal Free Hospital.
Dr Krell completed his medical degree at the University of Leeds in 2003. He later completed his specialist training in oncology at University College London and the Royal Free Hospital. He also holds a DPhil in Clinical Medicine gained from the University of Oxford's Wellcome Trust Centre for Human Genetics, funded by Cancer Research UK and HCA.
Dr Krell remains actively involved in clinical research and trials designed to find new cancer therapies for hepatobiliary, gastrointestinal and neuroendocrine tumours. He has published papers in peer-reviewed journals and has presented his work at both national and international conferences and meetings.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Daniel Krell
Education & training
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncology
Career & appointments
-
2012-09–2013-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AXA Healthcare Liability · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 946 |
| Annual physical exam | 99395 | 716 |
| Vaccination administration | 90471 | 1,148 |
| Minor procedure (skin) | 17110 | 83 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 540.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 7 · i10: 15
-
Long-term follow-up of Oncology across GB
DOI: 10.1158/euroclin.2026.0 · PMID: 39379831 · cited by 186
-
Validation of clinical scoring in Oncology
DOI: 10.6063/euroclin.2025.1 · PMID: 34571351 · cited by 24
-
Long-term follow-up of Oncology across GB
DOI: 10.6782/euroclin.2024.2 · PMID: 35646411 · cited by 142
-
Validation of clinical scoring in Oncology
DOI: 10.9644/euroclin.2023.3 · PMID: 30757185 · cited by 44
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2013
- national college of family doctors — Member · since 2013
- European Union of Medical Specialists (UEMS) — Member · since 2013
Patient reviews
- Bedside Manner
- 4.99
- Knowledge
- 5.00
- Wait Time
- 4.69
- Staff Friendliness
- 4.96
- Ease Of Appointment
- 4.84
- Value For Money
- 4.86
- Would Recommend Pct
- 98
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.daniel.krell@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
